Data from IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity

Authors:
  • HSHidekazu Shirota
    Hidekazu Shirota
  • DKDennis M. Klinman
    Dennis M. Klinman
  • SIShuku-Ei Ito
    Shuku-Ei Ito
  • HIHiroyasu Ito
    Hiroyasu Ito
  • MKMasato Kubo
    Masato Kubo
  • CIChikashi Ishioka
    Chikashi Ishioka

Abstract
Immune cells constitute a large fraction of the tumor microenvironment and modulate tumor progression. Clinical data indicate that chronic inflammation is present at tumor sites and that IL4 in particular is upregulated. Here, we demonstrate that T follicular helper (Tfh) cells arise in tumor-draining lymph nodes where they produce an abundance of IL4. Deletion of IL4-expressing Tfh cells improves antitumor immunity, delays tumor growth, and reduces the generation of immunosuppressive myeloid cells in the lymph nodes. These findings suggest that IL4 from Tfh cells affects antitumor immunity and constitutes an attractive therapeutic target to reduce immunosuppression in the tumor microenvironment, and thus enhance the efficacy of cancer immunotherapy. Cancer Immunol Res; 5(1); 61–71. ©2016 AACR.